A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer

导出原文传递

翻译打印收藏纠错

作者： Lee J. ^[1] ; Chen X. ^[2] ; Wang Y. ^[3] ; Nishimura T. ^[4] ; Li M. ^[5] ; Ishikawa S. ; Daikoku T. ; Kawai J. ; Tojo A. ; Gotoh N.

作者单位： Division of Cancer Cell Biology Cancer Research Institute Kanazawa University ^[1] Department of Gastroenterological Surgery Kanazawa University ^[2] Research Center for Experimental Modeling of Human Disease Institute for Experimental Animals ^[3] R&D Division Daiichi Sankyo Co. Ltd. ^[4] Division of Molecular Therapy The Institute of Medical Science The University of Tokyo ^[5]

关键词 Chk1 inhibitor Folate metabolism MTHFD2 One carbon metabolism S-phase check point Triple negative breast cancer

发布时间 2023-05-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biochemical and Biophysical Research Communications

2021年584卷

7-14页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer

Biochemical and Biophysical Research Communications

相似文献

Biochemical and Biophysical Research Communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer

Biochemical and Biophysical Research Communications

相似文献

Biochemical and Biophysical Research Communications

相关期刊

检索历史清除